Receptor Life Sciences, Inc.

📍 Seattle, United States👥 8 employees💰 Last funded Oct 2018
Pharmaceutical Manufacturing🌐 receptorlife.com
Website LinkedIn
Receptor Life Sciences combines proven drug delivery technologies, compelling therapeutic candidates, and traditional drug development research practices to pursue a robust range of prescription drug treatments for CNS indications. The delivery technologies, used in both oral and inhaled FDA-approved prescription drug products, represent a validated, strategic approach to overcoming traditional challenges of cannabinoid medicine. Receptor’s patented product candidates hold the potential to provide prescription treatments for a range of unmet medical needs, including anxiety and agitation in autism. More information is at www.ReceptorLife.com.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Receptor Life Sciences, Inc.?
Receptor Life Sciences, Inc. has 1 investors on record on gritt.io.
When did Receptor Life Sciences, Inc. last raise funding?
The most recent investment in Receptor Life Sciences, Inc. recorded on gritt.io was in October 2018.
What industry is Receptor Life Sciences, Inc. in?
Receptor Life Sciences, Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Receptor Life Sciences, Inc. based?
Receptor Life Sciences, Inc. is headquartered in Seattle, United States.